Table: begin end state 1 20 cytoplasmic 21 42 transmembrane 43 52 non-cytoplasmic 53 73 transmembrane 74 91 cytoplasmic 92 117 transmembrane 118 149 non-cytoplasmic 150 170 transmembrane 171 180 cytoplasmic 181 201 transmembrane 202 207 non-cytoplasmic 208 230 transmembrane 231 249 cytoplasmic 250 273 transmembrane 274 296 non-cytoplasmic 297 324 transmembrane 325 346 cytoplasmic 347 366 transmembrane 367 371 non-cytoplasmic 372 391 transmembrane 392 402 cytoplasmic 403 423 transmembrane 424 428 non-cytoplasmic 429 447 transmembrane 448 461 cytoplasmic
Input: >WP_012991424.1 NCBI__GCF_000025605.1:WP_012991424.1 MDLLRRKCYTVEEGKLVRKLGVVDLVALGIGGIIGAGIFVITGKVAHAYAGPGIVLAFLL CAVVVGISAFIYAELSTAYPISGSAYSYTYATVGEFVAWLVAWNLIVEYGVATAAVATGW SGYMRTLLKENLGLELPTFLSGPFNLEKGTFIDLLAFLALVAVFLLLTVGIKESATVNNI MVGIKLITLLVFVVFGLPHINFDNLNPFLPYGLTGVWHAASMIIFAYLGFDAVSTVAEEA KDPKRTLPAGLILSLAISTALYIVVSFTLVGMVNYKELNVPDALAYAMFRTGNHTLGSLI ATGAIITITSVMIVMGLGFTRVVFALSRDGLLPLWLSEVHPRFRTPYRATLLGGLVISLL GGFLPLEDLAKLVNIGTLFAYFWVAVGLILLRWRGDAEPTFKLPAAWFFVPLNMALLLFV MAGLGKETWVRFLLWNLLGLVIYFFYGYRNSRYYERTPAEM
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server